MedTrace Logo

Symbicort in Chronic Obstructive Pulmonary Disease

NCT00611520 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 64730

Last updated 2011-01-28

No results posted yet for this study

Summary

Under daily routine conditions and without any intervention by the sponsor regarding the selection of subjects, diagnostic procedures, therapeutic decisions (medicinal and non- medicinal therapy, dose, duration, etc.), routine assessments, the participating physicians (i.e. pneumologists and internists) are asked to document relevant data related to the budesonide/formoterole therapy in patients with COPD.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Kai Richter, MD · Medical Department AstraZeneca Germany

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2005-12-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00611520 on ClinicalTrials.gov